Login / Signup

Predictors of Shock-Reduction Programming and Its Impact on Implantable Cardioverter-Defibrillator Therapies and Mortality: The CERTITUDE Registry.

Sebastian E BeyerCamden HarrellSteven MullaneValentina KutyifaMalini MadhavanJonathan P PicciniGaurav A UpadhyayJames E IpGeorge ThomasChristopher F LiuSteven M MarkowitzDavid HayesBruce B LermanJim W Cheung
Published in: Journal of the American Heart Association (2024)
Adoption of SRP is low in real-world clinical practice. Age, clinical variables, and geographic factors are associated with use of SRP. In this study, SRP-associated decrease in mortality was limited to patients without ischemic heart disease.
Keyphrases
  • end stage renal disease
  • clinical practice
  • ejection fraction
  • chronic kidney disease
  • newly diagnosed
  • risk factors
  • prognostic factors
  • type diabetes
  • electronic health record